DrugDashboards

Diazepam

Diazepam Oral Solution (Concentrate) · DIAZEPAM 5 mg/mL · Solution · Oral · Chartwell RX, LLC

NDC 62135-0768-43 · 30 mL in 1 BOTTLE · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $1.05 per mL over the past year. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00$1.50Apr 2024Sep 2026$1.05
28 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$125.00
Reported to Texas DSHS · 2026 annual filing · Chartwell RX, LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2023)

$5,956
109 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for diazepam (other) in the next 90 days

sole-source market · price up 4% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA204433
TE code
AA
Approval date
Apr 14, 2014
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Diazepam Oral Solution (Concentrate) (Solution)

LabelerStrengthFirst seenLast seen
Chartwell RX, LLCDIAZEPAM 5 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Diazepam — NDC 62135-0768-43," retrieved September 3, 2026, https://drugdashboards.com/drug/62135076843.

Free to cite with attribution — see how the data is put together.